Neil K. Aaronson

Active 1985–2025

Also published as
Neil K Aaronson · NEIL K. AARONSON
252
Papers
60,184
Citations
125
h-index
246
i10-index

Citations

Citations per year for Neil K. Aaronson1987: 1 citations1988: 1 citations1989: 4 citations1990: 6 citations1991: 7 citations1992: 33 citations1993: 50 citations1994: 50 citations1995: 63 citations1996: 88 citations1997: 112 citations1998: 248 citations1999: 206 citations2000: 252 citations2001: 258 citations2002: 320 citations2003: 335 citations2004: 395 citations2005: 451 citations2006: 383 citations2007: 433 citations2008: 411 citations2009: 421 citations2010: 399 citations2011: 471 citations2012: 375 citations2013: 449 citations2014: 386 citations2015: 374 citations2016: 322 citations2017: 397 citations2018: 340 citations2019: 1,580 citations2020: 1,667 citations2021: 1,414 citations2022: 1,049 citations2023: 655 citations2024: 1,206 citations2025: 435 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,238 citing papers, 19.1% of this breakdownNetherlands: 2,300 citing papers, 10.4% of this breakdownUnited Kingdom: 2,018 citing papers, 9.1% of this breakdownGermany: 1,373 citing papers, 6.2% of this breakdownCanada: 1,117 citing papers, 5% of this breakdownAustralia: 1,088 citing papers, 4.9% of this breakdownItaly: 997 citing papers, 4.5% of this breakdownFrance: 905 citing papers, 4.1% of this breakdownSpain: 661 citing papers, 3% of this breakdownChina: 625 citing papers, 2.8% of this breakdownSweden: 611 citing papers, 2.7% of this breakdownBelgium: 578 citing papers, 2.6% of this breakdown
0%19.1%Other 25.6%

Fields

  • Medicine78.1%
  • Health Professions4.7%
  • Biochemistry, Genetics and Molecular Biology4.6%
  • Psychology3.1%
  • Economics, Econometrics and Finance3%
  • Social Sciences1.8%
  • Other4.7%

Topics

  • Cancer survivorship and care9.9%
  • Cancer-related cognitive impairment studies2.9%
  • Childhood Cancer Survivors' Quality of Life2.4%
  • Health Systems, Economic Evaluations, Quality of Life1.9%
  • Glioma Diagnosis and Treatment1.6%
  • Palliative Care and End-of-Life Issues1.5%
  • Other79.8%

Coauthors

All papers

Open in search
  1. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 1,409

  2. Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries

    Authors: , , , , , , , , , , - Journal of Clinical Epidemiology 1998 cited by 2,904

  3. EORTC QLQ-C30 Scoring Manual

    Authors: , , , , , - 1995 cited by 2,421

  4. Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations

    Authors: , , , , , , , , - Journal of Clinical Epidemiology 1998 cited by 2,318

  5. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20

    Authors: , , , , , , , , , , , , - European Journal of Cancer 2005 cited by 577

  6. Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 cited by 657

  7. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations

    Authors: , , , , , , , , , - Quality of Life Research 2011 cited by 944

  8. Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martina E. Schmidt, Karin Potthoff, Marc van Beurden, Hester S. A. Oldenburg, Gabe S. Sonke, Wim H. van Harten, Rachel Garrod, Kathryn H. Schmitz, Kerri M. Winters‐Stone, Miranda J. Velthuis, Dennis R. Taaffe, Willem van Mechelen, Marie José Kersten, Frans Nollet, Jennifer Wenzel, Joachim Wiskemann, Irma M. Verdonck‐de Leeuw, Johannes Brug - Cancer Treatment Reviews 2016 cited by 610

  9. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Quality of Life Research 2013 cited by 857

  10. Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research

    Authors: , , , , , , , , , , , , - Journal of Clinical Epidemiology 2019 cited by 364

  11. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up

    Authors: , , , , , , , , , , , , , , - The Lancet Neurology 2009 cited by 749

  12. The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials

    Authors: , , , , - European Journal of Cancer 1994 cited by 882

  13. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust

    Authors: , , , , , , , , - Journal of Clinical Epidemiology 2015 cited by 486

  14. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States

    Authors: , , , , , , , , , , , , , - European Journal of Cancer 2018 cited by 468

  15. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 cited by 121

  16. Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer

    Authors: , , , , , , , , , , , , , , , , , - European Journal of Cancer 2022 cited by 157

  17. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.

    Authors: , , , , , , , , , , , - Journal of Clinical Oncology 1996 cited by 1,218

  18. The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care

    Authors: , , , , , , , , , , , - European Journal of Cancer 2005 cited by 689

  19. Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2000 cited by 1,265

  20. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

    Authors: , , , , , , , , , - European Journal of Cancer 2010 cited by 392

  21. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the “Real-World”: Results from the Population-Based PROFILES Registry

    Authors: , , , , , , , - The Oncologist 2019 cited by 253

  22. Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With Radiotherapy

    Authors: , , , , , - Journal of Clinical Oncology 2008 cited by 688

  23. Efficacy of Internet-Based Cognitive Behavioral Therapy in Improving Sexual Functioning of Breast Cancer Survivors: Results of a Randomized Controlled Trial

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 161

  24. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Koller, Eva Nagele, Ourania Nicolatou‐Galitis, Anne Oberguggenberger, Claudia Schmalz, Zoë Winters - Annals of Oncology 2020 cited by 145